ID

27379

Beschreibung

Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors; ODM derived from: https://clinicaltrials.gov/show/NCT00756847

Link

https://clinicaltrials.gov/show/NCT00756847

Stichworte

Versionen (1)
  1. 10.11.17 10.11.17 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

10. November 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Cancer NCT00756847

Englisch

Eligibility Cancer NCT00756847

1 Formulare  
  1. StudyEvent: Eligibility
    1. Eligibility Cancer NCT00756847
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
confirmed diagnosis of:
Beschreibung

Diagnosis

Datentyp

boolean

Alias
UMLS CUI [1]
C0011900
advanced solid tumor that is no longer responding to therapies or
Beschreibung

Solid tumour Advanced Unresponsive to Treatment

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0280100
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C0205269
advanced or recurrent endometrial carcinoma or
Beschreibung

Endometrial Carcinoma Advanced | Recurrent Endometrial Cancer

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0476089
UMLS CUI [1,2]
C0205179
UMLS CUI [2]
C0278802
advanced or recurrent ovarian carcinoma or
Beschreibung

Ovarian Carcinoma Advanced | Ovarian cancer recurrent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0029925
UMLS CUI [1,2]
C0205179
UMLS CUI [2]
C0278689
unresectable (stage iiib or iv) nsclc
Beschreibung

Non-Small Cell Lung Carcinoma unresectable TNM clinical staging

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C1519810
UMLS CUI [1,3]
C3258246
ecog performance status 0-1 (ecog status of 2 may be considered following discussion and agreement with sponsor)
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
adequate organ and bone marrow function as defined by hematological and serum chemistry limits
Beschreibung

Organ function Hematologic | Bone Marrow function Hematologic | Organ function Serum Chemistry Measurement | Bone Marrow function Serum Chemistry Measurement

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0678852
UMLS CUI [1,2]
C0205488
UMLS CUI [2,1]
C0005953
UMLS CUI [2,2]
C0031843
UMLS CUI [2,3]
C0205488
UMLS CUI [3,1]
C0678852
UMLS CUI [3,2]
C1883010
UMLS CUI [4,1]
C0005953
UMLS CUI [4,2]
C0031843
UMLS CUI [4,3]
C1883010
at least 18 years old
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
both men and women must practice adequate contraception
Beschreibung

Contraceptive methods

Datentyp

boolean

Alias
UMLS CUI [1]
C0700589
informed consent
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
restriction of some therapies/medications within specific timeframes prior to enrollment and during the study including prior therapy with pi3k, akt, or mtor inhibitors, cytotoxic chemotherapy, biologic agents, nitrosoureas or mitomycin c, small-molecule kinase inhibitors, non-cytotoxic hormonal agents
Beschreibung

PI3K | AKT | mTOR Inhibitor | Cytotoxic Chemotherapy | Biological Factors | Nitrosoureas | Mitomycin | Other Coding | Non-Cytotoxic Agent Hormonal

Datentyp

boolean

Alias
UMLS CUI [1]
C0044602
UMLS CUI [2]
C0164786
UMLS CUI [3]
C2746052
UMLS CUI [4]
C0677881
UMLS CUI [5]
C0005515
UMLS CUI [6]
C0028210
UMLS CUI [7]
C0002475
UMLS CUI [8]
C3846158
UMLS CUI [9,1]
C2827065
UMLS CUI [9,2]
C0458083
known allergy or hypersensitivity to any of the components of the treatment formulations
Beschreibung

Hypersensitivity Investigational New Drugs Component

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [1,3]
C1705248
taking oral corticosteroids chronically or > 1 mg/day warfarin
Beschreibung

Adrenal Cortex Hormones Oral chronic | Warfarin U/day

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C0205191
UMLS CUI [2,1]
C0043031
UMLS CUI [2,2]
C0456683
not recovered from the toxic effects of prior therapy
Beschreibung

Toxic effect Due to Prior Therapy | Recovery Lacking

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0600688
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C1514463
UMLS CUI [2,1]
C2004454
UMLS CUI [2,2]
C0332268
history of diabetes mellitus.
Beschreibung

Diabetes Mellitus

Datentyp

boolean

Alias
UMLS CUI [1]
C0011849
uncontrolled intercurrent illness
Beschreibung

Comorbidity Uncontrolled

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205318
pregnant or breastfeeding
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
congestive heart failure, unstable angina, or a myocardial infarction within 3 months of entering the study.
Beschreibung

Congestive heart failure | Angina, Unstable | Myocardial Infarction

Datentyp

boolean

Alias
UMLS CUI [1]
C0018802
UMLS CUI [2]
C0002965
UMLS CUI [3]
C0027051
hiv positive
Beschreibung

HIV Seropositivity

Datentyp

boolean

Alias
UMLS CUI [1]
C0019699
diagnosis of another malignancy may exclude subject from study
Beschreibung

Cancer Other

Datentyp

boolean

Alias
UMLS CUI [1]
C1707251
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Cancer NCT00756847

1 Formulare
  1. StudyEvent: Eligibility
    1. Eligibility Cancer NCT00756847
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Diagnosis
Item
confirmed diagnosis of:
boolean
C0011900 (UMLS CUI [1])
Solid tumour Advanced Unresponsive to Treatment
Item
advanced solid tumor that is no longer responding to therapies or
boolean
C0280100 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0205269 (UMLS CUI [1,3])
Endometrial Carcinoma Advanced | Recurrent Endometrial Cancer
Item
advanced or recurrent endometrial carcinoma or
boolean
C0476089 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0278802 (UMLS CUI [2])
Ovarian Carcinoma Advanced | Ovarian cancer recurrent
Item
advanced or recurrent ovarian carcinoma or
boolean
C0029925 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0278689 (UMLS CUI [2])
Non-Small Cell Lung Carcinoma unresectable TNM clinical staging
Item
unresectable (stage iiib or iv) nsclc
boolean
C0007131 (UMLS CUI [1,1])
C1519810 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
ECOG performance status
Item
ecog performance status 0-1 (ecog status of 2 may be considered following discussion and agreement with sponsor)
boolean
C1520224 (UMLS CUI [1])
Organ function Hematologic | Bone Marrow function Hematologic | Organ function Serum Chemistry Measurement | Bone Marrow function Serum Chemistry Measurement
Item
adequate organ and bone marrow function as defined by hematological and serum chemistry limits
boolean
C0678852 (UMLS CUI [1,1])
C0205488 (UMLS CUI [1,2])
C0005953 (UMLS CUI [2,1])
C0031843 (UMLS CUI [2,2])
C0205488 (UMLS CUI [2,3])
C0678852 (UMLS CUI [3,1])
C1883010 (UMLS CUI [3,2])
C0005953 (UMLS CUI [4,1])
C0031843 (UMLS CUI [4,2])
C1883010 (UMLS CUI [4,3])
Age
Item
at least 18 years old
boolean
C0001779 (UMLS CUI [1])
Contraceptive methods
Item
both men and women must practice adequate contraception
boolean
C0700589 (UMLS CUI [1])
Informed Consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
PI3K | AKT | mTOR Inhibitor | Cytotoxic Chemotherapy | Biological Factors | Nitrosoureas | Mitomycin | Other Coding | Non-Cytotoxic Agent Hormonal
Item
restriction of some therapies/medications within specific timeframes prior to enrollment and during the study including prior therapy with pi3k, akt, or mtor inhibitors, cytotoxic chemotherapy, biologic agents, nitrosoureas or mitomycin c, small-molecule kinase inhibitors, non-cytotoxic hormonal agents
boolean
C0044602 (UMLS CUI [1])
C0164786 (UMLS CUI [2])
C2746052 (UMLS CUI [3])
C0677881 (UMLS CUI [4])
C0005515 (UMLS CUI [5])
C0028210 (UMLS CUI [6])
C0002475 (UMLS CUI [7])
C3846158 (UMLS CUI [8])
C2827065 (UMLS CUI [9,1])
C0458083 (UMLS CUI [9,2])
Hypersensitivity Investigational New Drugs Component
Item
known allergy or hypersensitivity to any of the components of the treatment formulations
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C1705248 (UMLS CUI [1,3])
Adrenal Cortex Hormones Oral chronic | Warfarin U/day
Item
taking oral corticosteroids chronically or > 1 mg/day warfarin
boolean
C0001617 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,3])
C0043031 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
Toxic effect Due to Prior Therapy | Recovery Lacking
Item
not recovered from the toxic effects of prior therapy
boolean
C0600688 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,3])
C2004454 (UMLS CUI [2,1])
C0332268 (UMLS CUI [2,2])
Diabetes Mellitus
Item
history of diabetes mellitus.
boolean
C0011849 (UMLS CUI [1])
Comorbidity Uncontrolled
Item
uncontrolled intercurrent illness
boolean
C0009488 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Congestive heart failure | Angina, Unstable | Myocardial Infarction
Item
congestive heart failure, unstable angina, or a myocardial infarction within 3 months of entering the study.
boolean
C0018802 (UMLS CUI [1])
C0002965 (UMLS CUI [2])
C0027051 (UMLS CUI [3])
HIV Seropositivity
Item
hiv positive
boolean
C0019699 (UMLS CUI [1])
Cancer Other
Item
diagnosis of another malignancy may exclude subject from study
boolean
C1707251 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video